The new generation of high-sensitivity assays for cardiac troponin T (hs–cTnT) allows the identification of minimal cardiac damage [36] and has been associated with poor outcomes in ischemic and non-ischemic heart disease [37]. This evidence concerns the gene TNNT2 and coronary artery disorder.